What Documents Do I Need to Sell in Europe?

Selling medical devices in Europe requires specific documentation centered around CE marking requirements and comprehensive EU medical device documentation. The core documents include technical documentation files, declarations of conformity, and quality management system certificates. Additionally, non-US manufacturers typically need an authorized representative in Europe and must comply with current EU MDR requirements rather than the previous directive standards.

What Documents Do You Actually Need for CE Marking?

CE marking compliance requires three fundamental categories of documents that work together to demonstrate your device meets European safety and performance standards for legal market access:

• Technical documentation file – A comprehensive regulatory profile including device descriptions, intended use statements, risk management documentation, clinical evaluation reports, and post-market surveillance plans that demonstrates substantial equivalence or provides clinical evidence supporting safety claims
• Declaration of conformity – Your formal statement identifying specific harmonized standards, applicable directives or regulations, and confirmation that conformity assessment procedures have been completed successfully
• Quality management system certificates – ISO 13485 certificates issued by notified bodies that validate your organization maintains appropriate quality controls throughout design, production, and post-market activities

These three document categories form the foundation of your regulatory submission and must remain current throughout your device’s market presence. Each component undergoes scrutiny by regulatory authorities and notified bodies, making thorough preparation essential for successful market entry and ongoing compliance.

How Do You Prepare Technical Documentation That Meets EU Standards?

Technical documentation preparation follows a systematic approach with four essential components that must align with current MDR requirements and demonstrate ongoing compliance throughout the device lifecycle:

• Device description and specification documentation – Technical drawings, material specifications, software documentation, and clear intended use statements precise enough for regulatory authorities to understand exactly what you’re placing on the market
• Risk management files – ISO 14971 compliant documentation of identified hazards, risk analysis results, implemented risk control measures, and evidence that residual risks are acceptable when weighed against clinical benefits
• Clinical evaluation reports – Synthesized clinical data supporting your device’s safety and performance through literature reviews, post-market data analysis, clinical investigations, or substantial equivalence demonstrations with comparative analysis
• Post-market surveillance plans – Detailed monitoring strategies specifying data collection methods, adverse event reporting procedures, systematic review processes, and provisions for field safety corrective actions

Each documentation component builds upon the others to create a comprehensive regulatory profile that authorities can evaluate efficiently. The systematic approach ensures no critical elements are overlooked while maintaining consistency across all technical file sections, ultimately supporting faster regulatory review and approval timelines.

What’s the Difference Between MDR and MDD Documentation Requirements?

MDR documentation requirements represent a significant evolution from previous MDD standards, introducing enhanced requirements across multiple regulatory areas:

• Enhanced clinical evidence requirements – More detailed clinical evaluation reports with regular updates, systematic literature reviews for Class I devices, and stricter clinical data requirements for higher-risk devices with ongoing evaluation obligations
• Expanded post-market surveillance documentation – Detailed surveillance plans, periodic safety update reports, and systematic adverse event analysis now required for devices that had minimal post-market obligations under MDD
• Mandatory unique device identification (UDI) systems – Comprehensive labeling updates, database registration requirements, UDI implementation strategies, and EUDAMED registration confirmation integrated into technical documentation
• Strengthened quality management system requirements – Enhanced competency requirements for regulatory compliance personnel, detailed clinical evaluation procedures, and comprehensive documentation of decision-making processes throughout device lifecycles

These expanded requirements reflect the EU’s commitment to enhanced patient safety and device traceability throughout the European market. The transition from MDD to MDR requires most manufacturers to substantially update their existing documentation and implement new quality management processes, making early preparation essential for maintaining market access.

Do You Need an Authorized Representative and What Documents Are Required?

Non-US manufacturers must designate an authorized representative before placing devices on the European market, with specific documentation requirements that establish legal responsibility and regulatory compliance:

• Written authorization agreement – Formal contract specifying exact responsibilities including technical documentation maintenance, authority communications, incident reporting, and corrective action coordination with clear delineation between manufacturer and representative obligations
• Competency demonstration documentation – Evidence of your representative’s regulatory expertise, sufficient resources, appropriate quality systems, and established procedures for handling authority communications and post-market surveillance activities
• Labeling compliance requirements – Clear identification of your authorized representative’s name, address, and contact information prominently displayed on all device packaging and instructions for use
• Ongoing compliance documentation – Continuous maintenance of representative relationship records, communication logs, and evidence of fulfilled regulatory obligations throughout your device’s market presence

Your authorized representative becomes legally responsible for ensuring regulatory compliance and serves as the primary European contact for authorities, making careful selection and documentation critical for successful market access. Additionally, In-Country Representation services can streamline compliance across multiple markets by consolidating representation roles, allowing manufacturers to maintain greater control while minimizing operational disruption when entering several international markets simultaneously.

How MedEnvoy Global Helps With EU Medical Device Documentation

Successfully navigating European medical device documentation requires thorough preparation, attention to regulatory detail, and often professional guidance to ensure compliance. The complexity of current requirements makes partnering with experienced regulatory experts increasingly valuable for manufacturers seeking efficient market access. MedEnvoy Global helps medical device companies streamline their European documentation requirements and representation needs through comprehensive regulatory support services:

• Complete technical documentation file preparation and review for MDR compliance
• Authorized representative services with full regulatory responsibility delegation
• Clinical evaluation report development and ongoing maintenance
• Post-market surveillance plan implementation and adverse event reporting
• Quality management system gap analysis and ISO 13485 compliance support
• EUDAMED registration and UDI system implementation assistance

Ready to accelerate your European market entry with expert regulatory guidance? Contact our team today to discuss how we can simplify your compliance journey and ensure your medical devices meet all EU requirements efficiently.

Related Articles

• What Regulatory Obligations Require Authorized Representative Oversight?
• What Does an Authorized Representative Do?
• How Do I Choose Between European Markets?
• Can a Swiss Authorized Representative Handle Multiple Manufacturers?
• What Is a CHRN in Switzerland?